Ashouri, E., Rajalingam, K., Barani, S., Farjadian, S., Ghaderi, A., & Rajalingam, R. (2021). Coexistence of inhibitory and activating killer-cell immunoglobulin-like receptors to the same cognate HLA-C2 and Bw4 ligands confer breast cancer risk. Sci Rep.

Ashouri, Elham, Karan Rajalingam, Shaghik Barani, Shirin Farjadian, Abbas Ghaderi, e Raja Rajalingam. "Coexistence of Inhibitory and Activating Killer-cell Immunoglobulin-like Receptors to the Same Cognate HLA-C2 and Bw4 Ligands Confer Breast Cancer Risk." Sci Rep 2021.

Ashouri, Elham, et al. "Coexistence of Inhibitory and Activating Killer-cell Immunoglobulin-like Receptors to the Same Cognate HLA-C2 and Bw4 Ligands Confer Breast Cancer Risk." Sci Rep 2021.